Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 31 n° 321

Posts Tagged ‘financial result’

Limelight Networks, Inc. to Issue Second Quarter 2018 Financial Results

Posted by fidest press agency su sabato, 30 giugno 2018

Limelight Networks, Inc. (Nasdaq:LLNW) will report financial results for the second quarter of 2018 on Thursday, July 19, 2018 at 4:00 p.m. EDT (1:00 p.m. PDT).Management will host a quarterly conference call for investors at 4:30 p.m. EDT (1:30 p.m. PDT). Investors can access this call toll-free at (877) 296-5190 within the United States or +1 (412) 317-5233 outside of the United States.The conference call will also be audio cast live from http://investors.limelight.com/ and a replay will be available following the call from the Company’s website. Limelight Networks, a global leader in digital content delivery, empowers customers to better engage online audiences by enabling them to securely manage and globally deliver digital content, on any device. The company’s Limelight Orchestrate Platform includes a global infrastructure with a fully-integrated suite of capabilities and services to help you address all your content delivery needs. The Orchestrate Platform solves your most important content delivery challenges so you can deliver the next great digital experience anywhere. For more information, please visit http://www.limelight.com and follow us on Twitter, Facebook and LinkedIn.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Teva to Report Third Quarter 2017 Financial Results

Posted by fidest press agency su giovedì, 12 ottobre 2017

Teva_PharmaceuticalTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will release its third quarter 2017 financial results on Thursday, November 2, 2017 at 7:00 a.m. ET.Teva will host a conference call and live webcast on the same day, at 8:00 a.m. ET to discuss its third quarter 2017 results and overall business environment. A Question & Answer session will follow this discussion.
In order to participate, please dial the following numbers (at least 10 minutes before the scheduled start time): United States 1-866-869-2321; Canada 1-866-766-8269 or International +44(0) 203 0095710; passcode: 91932782. For a list of other international toll-free numbers, click here.A live webcast of the call will also be available on Teva’s website at: http://www.ir.tevapharm.com Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by approximately 200 million patients in 100 markets every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has the world-leading innovative treatment for multiple sclerosis as well as late-stage development programs for other disorders of the central nervous system, including movement disorders, migraine, pain and neurodegenerative conditions, as well as a broad portfolio of respiratory products. Teva is leveraging its generics and specialty capabilities in order to seek new ways of addressing unmet patient needs by combining drug development with devices, services and technologies. Teva’s net revenues in 2016 were $21.9 billion. For more information, visit http://www.tevapharm.com.

Posted in Economia/Economy/finance/business/technology, Spazio aperto/open space | Contrassegnato da tag: , , | Leave a Comment »